DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Omni Shoreham Hotel

2016 年 12 月 05 日 1:00 下午 - 2016 年 12 月 06 日 5:00 下午

2500 Calvert Street NW, , Washington, DC 20008 , USA

Advancing the Science of Study Endpoints

Examine global strategies for selecting study endpoints and the impact of endpoints during the analysis of clinical evidence for various types of drug approval processes.

Session 7: Clinical Trial Grade Wearables – The Current State of the Science

Speaker(s)

Bill  Byrom, PHD

Session Co-Chair

Bill Byrom, PHD

Signant Health , United Kingdom

Vice President, Product Intelligence and Positioning; Principal, eCOA Science

Chad  Gwaltney, PHD

Moderator

Chad Gwaltney, PHD

Gwaltney Consulting, United States

President

Elektra  Papadopoulos, MD, MPH

Panelist

Elektra Papadopoulos, MD, MPH

AbbVie, United States

Director, Patient Experience Data and Strategy

Robert Alan Vigersky, MD, FACP

Panelist

Robert Alan Vigersky, MD, FACP

Medtronic, United States

Medical Director

Robert  DiCicco, PHARMD

Panelist

Robert DiCicco, PHARMD

TransCelerate Biopharma Inc., United States

Vice President, Portfolio Management

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。